July 25, 2017 1:45 PM ET

Pharmaceuticals

Company Overview of Relypsa, Inc.

Key Executives for Relypsa, Inc.

NameBoard RelationshipsTitleAge
J. Scott Garland MBA11 RelationshipsPresident48
Kristine M. Ball No RelationshipsChief Financial Officer, Principal Accounting Officer and Senior Vice President45
Lance Berman M.D., M.SNo RelationshipsChief Medical Officer and Senior Vice President46
Stephen D. Harrison Ph.D.No RelationshipsChief Scientific Officer and Senior Vice President52
Ronald A. Krasnow J.D., Esq.No RelationshipsSenior Vice President, General Counsel and Secretary55

Relypsa, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Daniel K. Spiegelman B.A., M.B.A. 20 RelationshipsBioMarin Pharmaceutical Inc.58
Paul J. Hastings 210 RelationshipsOncoMed Pharmaceuticals, Inc.57
David W. J. McGirr MBA 40 RelationshipsCubist Pharmaceuticals LLC63
Craig J. Hawker Ph.D. 21 RelationshipsTricida, Inc.--
Thomas J. Schuetz M.D., Ph.D. 47 RelationshipsAudentes Therapeutics, Inc.56
View All Board Members

Relypsa, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee MBADavid W. J. McGirr40 Relationships3 Executives
Compensation Committee Paul J. Hastings210 Relationships3 Executives
Nominating Committee B.A., M.B.A. Daniel K. Spiegelman20 Relationships3 Executives
Corporate Governance Committee B.A., M.B.A. Daniel K. Spiegelman20 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
428.1K
Bonus
441.7K
Total Short Term Compensation
613.1K
Total Value of Options
8.2M
Compensation as of Fiscal Year
Relypsa, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

VANC Pharmaceuticals Inc. Appoints Mark Kunzli as Director of Pharmacy Solutions
July 25, 2017 6:52 AM ET
Veritas Pharma Inc. Appoints Peter Doig to its Advisory Board
July 24, 2017 11:23 PM ET
OWC Pharmaceutical Research Corp. Appoints Stanley Hirsch to Serve as Chairman of the Board of Directors
July 24, 2017 8:11 PM ET
China Traditional Chinese Medicine Holdings Co. Announces Executive Appointments
July 24, 2017 12:43 PM ET
Torrent Pharmaceuticals Limited Announces Resignation of Ashish Nanda, Independent Director
July 22, 2017 10:03 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Relypsa, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.